ActHIB (Sanofi Pasteur Inc.)
Welcome to the PulseAid listing for the ActHIB drug offered from Sanofi Pasteur Inc.. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: | Sanofi Pasteur Inc. |
NON-PROPRIETARY NAME: | HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN |
SUBSTANCE NAME: | |
TYPE: | VACCINE |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 1993-03-30 |
END MARKETING DATE: | 0000-00-00 |
ActHIB VACCINE Details:
Item Description | ActHIB from Sanofi Pasteur Inc. |
LABELER NAME: | Sanofi Pasteur Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 1993-03-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49281-545_596df50c-179e-4714-a293-569f75a90e9e |
PRODUCT NDC: | 49281-545 |
APPLICATION NUMBER: | BLA103935 |